A leading center for practice-changing discovery and comprehensive cancer treatment, the Sidney Kimmel Cancer Center of the Thomas Jefferson University has been known as a Designated Center by the National Cancer Institute since 1996, and is one of only 70 institutions in the nation to hold this prestigious recognition. SKCC is committed to delivering the most advanced, personalized cancer care, made possible through their scientific discoveries and breakthroughs in detecting and treating cancer. SKCC provides access to advanced clinical trials and novel treatment strategies throughout the Greater Delaware Valley. SKCC is routinely ranked amongst the top hospitals for cancer care in the United States by US News & World Report, the multi-disciplinary teams at SKCC bring together specialists for treatment planning, which results in some of the highest survival rates in the nation.
Unique Clinical Trial for Melanoma Patients Begins at Sidney Kimmel Cancer Center
Understanding Genetic Test Results for Prostate Cancer: Needs for Men Identified
Eye Cancer Cases in North Carolina and Alabama Baffle Physicians
SKCC Researchers Receive Melanoma Research Alliance Team Science Award
Brittany Simone Recognized With AACR Scholar-in-Training Award